相关实验视频

Updated: Jun 18, 2025

Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons

Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons

Published on: August 26, 2021

早期的核表型和人类iPSC衍生天体细胞中的反应性转化来自ALS患者的SOD1突变

Vincent Soubannier^1,2, Mathilde Chaineau^1,2, Lale Gursu^1,2

¹Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada.

|August 2, 2024

概括

肌缩侧面硬化症 (ALS) 涉及运动神经元死亡. SOD1突变天体细胞表现出早期的核变化,包括氧化应激和DNA损伤,有助于ALS的反应性星化和运动神经元退化.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
遗传学遗传学是一个

背景情况:

肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,其特征是运动神经元 (MN) 死亡.
质细胞,特别是星球细胞,在ALS中MN退化中发挥着关键作用.
Cu/Zn超氧化物脱酶1 (SOD1) 基因的突变与家族性ALS有关,而SOD1突变的天体细胞通过不完全理解的机制促进了MN死亡.

研究的目的:

研究SOD1突变对天体细胞生理学的影响,并确定早期细胞变化.
鉴定SOD1突变的ALS患者所产生的星细胞中的分子和形态变化的特征.

主要方法:

人类诱导多能干细胞 (iPSC) 衍生天体细胞的生成来自具有SOD1突变 (SOD1 ((A4V) 和SOD1 ((D90A)) 的ALS患者,并控制同源性iPSCs.
在突变和控制天体细胞之间对分子和形态表型的比较分析.

主要成果:

与同位素对照组相比,SOD1突变的天体细胞表现出分子和形态变化,表明有反应性天体化.
在SOD1突变天体细胞中观察到早期的核表型,包括增加的氧化应激,DNA损伤和核SOD1蛋白积累.
这些核变化是在反应性天体细胞表型的发展之前或与之相吻合的.

结论:

SOD1突变会诱导星体细胞中早期的细胞自主表型.
这些表型,包括核变异和反应性星病,可能通过影响星细胞-MN通信,导致ALS的发病.

关键词:

/超氧化物脱酶 1 的 Cu/Zn.造成的DNA损伤是DNA损伤.骨髓缩侧面硬化症 (ALS) 是一种星球细胞是星球细胞.核氧化应激是一种核氧化应激.反应性星化反应性星化

更多相关视频

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis

Published on: June 23, 2022

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein

Published on: June 6, 2025

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.